EORTC

Skip to Main Content Area

Markers in Cancer: Abstracts submission will close soon

EORTC study shows radiotherapy and surgery provide excellent regional control for breast cancer patients

EORTC led intergroup trial investigates Imatinib failure-free survival in patients with localized GIST

EORTC Melanoma Group study selects AS15 adjuvant for active immunization with MAGE A3 protein for treatment of metastatic melanoma

EORTC study identifies patients with anaplastic oligodendroglioma that benefit from adjuvant PCV chemotherapy

EORTC BOS 2 trial evaluating targeted agents for patients with resectable liver metastases from colorectal cancer

Colorectal Cancer Biomarker Screening Platform

rss

HIGHLIGHTS

TESARO, BIG and EORTC announce collaboration for niraparib in breast cancer

In memory of Maurice Staquet, the first director of the EORTC Data Center (1930 – 2013)

Dr. Emad Shash discusses organizational and regulatory constraints for international clinical trials for rare cancers

Joint EORTC-ESGO session to focus on translational research (19-22 October 2013)

SAVE THE DATE

rss

Markers in Cancer: Registration is now open

Joint ECCO-AACR-EORTC-ESMO Workshop on Methods in clinical cancer research

22 June 2013 - 28 June 2013

ONE-DAY INTRODUCTION TO EORTC TRIALS (Brussels, Belgium)

13 September 2013

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

19 October 2013 - 23 October 2013

rss

RESEARCH UPDATE

Radiotherapy remains the treatment of first choice for high-risk low-grade...

Gender plays a role in progression-free and disease-specific survival according to five EORTC studies in stage III-IV melanoma patients

EORTC Abstracts at ASCO 2013 in Chicago

New phase III EORTC transatlantic intergroup trial opens for patients with resected head of pancreas adenocarcinoma

The primary intent of this website is the communication of clinical cancer research with oncologists and health professionals in the field, but it is recognized that the information presented here might also be of interest to patients, charities, funding organizations and the general public.
        Disclaimer
  
HOW TO REACH USAvenue Mounier, 83/11
1200 Brussels
Belgium
Directions & Accomodations
+32 2 774 16 11
eortc [ at ] eortc.be

 
Contact form
        CAREER OPPORTUNITIES  
We are always looking for new talents. Please find hereunder the current positions open at EORTC HQ in Brussels.
Current openings
 This site complies with the HONcode standard for trustworthy health information: verify here.
SPECIAL THANKSEORTC is partially supported by the Belgian National Lottery and by the Belgian Federal Science Policy Office.
Funding
    Last website update:     18 June 2013  

      Home
Sitemap
EORTC Intranet
UP
    

Investigator's Area

HIGHLIGHTS

SAVE THE DATE

RESEARCH UPDATE

HOW TO REACH US

CAREER OPPORTUNITIES

SPECIAL THANKS